JPS57128624A - Preventive and remedy for disease caused by srs-a - Google Patents

Preventive and remedy for disease caused by srs-a

Info

Publication number
JPS57128624A
JPS57128624A JP1470581A JP1470581A JPS57128624A JP S57128624 A JPS57128624 A JP S57128624A JP 1470581 A JP1470581 A JP 1470581A JP 1470581 A JP1470581 A JP 1470581A JP S57128624 A JPS57128624 A JP S57128624A
Authority
JP
Japan
Prior art keywords
compound shown
srs
formula
compound
remedy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1470581A
Other languages
English (en)
Inventor
Yoshitaka Maki
Shinji Terao
Masazumi Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to JP1470581A priority Critical patent/JPS57128624A/ja
Publication of JPS57128624A publication Critical patent/JPS57128624A/ja
Pending legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP1470581A 1981-02-02 1981-02-02 Preventive and remedy for disease caused by srs-a Pending JPS57128624A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1470581A JPS57128624A (en) 1981-02-02 1981-02-02 Preventive and remedy for disease caused by srs-a

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1470581A JPS57128624A (en) 1981-02-02 1981-02-02 Preventive and remedy for disease caused by srs-a

Publications (1)

Publication Number Publication Date
JPS57128624A true JPS57128624A (en) 1982-08-10

Family

ID=11868584

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1470581A Pending JPS57128624A (en) 1981-02-02 1981-02-02 Preventive and remedy for disease caused by srs-a

Country Status (1)

Country Link
JP (1) JPS57128624A (ja)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851586A (en) * 1985-09-20 1989-07-25 The Upjohn Company 1,4-naphthalenediol and 1,4-hydroquinone derivatives
US4939169A (en) * 1985-09-20 1990-07-03 The Upjohn Company 1,4-naphthalenediol and 1,4-hydroquinone derivatives
WO2002085297A3 (en) * 2001-04-24 2003-04-03 Epigenesis Pharmaceuticals Inc Compositions & formulations with a non-glucocorticoid steroid &/or a ubiquinone & kit for treatment of respiratory & lung disease
WO2003075900A3 (de) * 2002-03-09 2004-06-03 Mse Pharmazeutika Gmbh Verwendung von ubichinonen zur beeinflussung der histaminwirkung zur behandlung von bronchitis, asthma, allergischen krankheiten
WO2007086480A1 (ja) * 2006-01-25 2007-08-02 Kaneka Corporation 血圧正常化組成物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5320432A (en) * 1976-08-11 1978-02-24 Eisai Co Ltd Remedies for bronchial asthma, containing coenzyme q as main component
JPS5489036A (en) * 1977-12-27 1979-07-14 Eisai Co Ltd Remedy and preventive for hypersensitivity to light

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5320432A (en) * 1976-08-11 1978-02-24 Eisai Co Ltd Remedies for bronchial asthma, containing coenzyme q as main component
JPS5489036A (en) * 1977-12-27 1979-07-14 Eisai Co Ltd Remedy and preventive for hypersensitivity to light

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851586A (en) * 1985-09-20 1989-07-25 The Upjohn Company 1,4-naphthalenediol and 1,4-hydroquinone derivatives
US4939169A (en) * 1985-09-20 1990-07-03 The Upjohn Company 1,4-naphthalenediol and 1,4-hydroquinone derivatives
WO2002085297A3 (en) * 2001-04-24 2003-04-03 Epigenesis Pharmaceuticals Inc Compositions & formulations with a non-glucocorticoid steroid &/or a ubiquinone & kit for treatment of respiratory & lung disease
US7456161B2 (en) 2001-04-24 2008-11-25 Epigenesis Pharmaceuticals, Llc Use of DHEA and DHEA-sulfate for the treatment of chronic obstructive pulmonary disease
WO2003075900A3 (de) * 2002-03-09 2004-06-03 Mse Pharmazeutika Gmbh Verwendung von ubichinonen zur beeinflussung der histaminwirkung zur behandlung von bronchitis, asthma, allergischen krankheiten
WO2007086480A1 (ja) * 2006-01-25 2007-08-02 Kaneka Corporation 血圧正常化組成物
JPWO2007086480A1 (ja) * 2006-01-25 2009-06-25 株式会社カネカ 血圧正常化組成物

Similar Documents

Publication Publication Date Title
Soudamini et al. Inhibition of lipid peroxidation and cholesterol levels in mice by curcumin
IE870194L (en) Use of lithium compounds in senile dementia
ATE448194T1 (de) Verwendung einer pharmazeutischen zusammensetzung mit einem para-aminophenylessigsäurederivat für die behandlung von entzündlichen erkrankungen des magen-darmtrakts
EP0190682B1 (en) Novel disubstituted 4-hydroxyphenylthio anilides
JP2004506657A (ja) 天然および合成ｈｃａのバイオアベイラブルな組成物
Salmon et al. Evaluation of colloidal bismuth (De-Nol) in the treatment of duodenal ulcer employing endoscopic selection and follow up
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
EP0338595A1 (en) Hydroxyphenylthioalkylketoalcohols
JPS54160740A (en) Anti-fibrotic agent
JPS57128624A (en) Preventive and remedy for disease caused by srs-a
DE3465590D1 (en) Hydroxamic acids, their preparation and their use in pharmaceutical compositions
Fanburg Prostaglandins and the lung
EP0133935B1 (de) p-Oxibenzoesäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneimitteln mit hypolipämischer Wirkung
NO175885C (no) Fremgangsmåte for fremstilling av et salicylsyreholdig middel for lokal behandling av hudsykdommer med avskalling
ES8205190A1 (es) Un procedimiento para la preparacion del acido 3,7,11,15-tetrametil-2,4,6,10-14-hexadecapentaenoico.
ES473534A1 (es) Procedimiento para la preparacion de analogos de prostaci- clina
DE2759108A1 (de) Verwendung von alpha -mercapto-beta- aryl-acrylsaeuren bei der steigerung des zinkgehaltes im serum und im gewebe
EP0163683A1 (en) Chromone-2-carboxilic acid derivatives as cardiovascular agents
EP0383481A3 (en) Anesthetic oral compositions
US5071876A (en) Novel disubstituted 4-hydroxyphenylthio anilides
DE69008428T2 (de) Leukotrienantagonisten.
US5475028A (en) 2-aminoethanesulfonic acid zinc complex
GB1587638A (en) Iodophenoxyphenylalkenoic acid derivatives and pharmaceutical preparations containing them
JPS6293225A (ja) 消炎鎮痛剤
US5225444A (en) Disubstituted 4-hydroxyphenylthio anilides